INGN

Inogen Inc Common Stock (INGN)

Stock · NASDAQ · Health Care

$6.26as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

Medical device growth debate touches Inogen sector. A recent Yahoo article examined whether ResMed or Stryker offers a better path to capture medical device growth. Inogen operates in the same medical device market, so the analysis is relevant to how the sector is being evaluated. The discussion may influence how market participants view companies that provide portable oxygen solutions.

Active signals

Resistance level
$6.33
Industry
Industrial Specialties

What INGN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike39+2.0%51%
Bollinger Band Breakout26-5.5%38%
Bollinger Band Breakdown24-2.1%50%
200-Day Moving Average TouchActive now14-8.2%29%
Any 20-session window (baseline)-1.8%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a porta…

Sector
Health Care
Industry
Industrial Specialties
Employees
753

Fundamentals

1-day range
$6.2$6.37
Market cap
$175.71M
P/E (trailing)
—
P/E (forward)
-39.34
EPS (trailing)
$-0.90
Dividend yield
—
Beta
1.55
Avg. volume
299.7K
52-week range
$5.05$9.13
Next earnings: November 5, 2026 · EPS estimate $-0.06After Closeconfirmed

How Inogen Inc Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$295.30MSG&A$165.07M (56%)Cost of Revenue$163.84M (55%)R&D$19.40M (7%)INGN

Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub

Gross Profit$154.26M(52%)
Operating Income-$30.21M(-10%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$12
+91.8%
Median
$12
+91.8%
Low
$12
+91.8%

Inogen Inc Common Stock Competitors

Chosen by industry and closest market cap.

  • INGN
    Inogen Inc Common Stock
    $6.25
    ▼ 0.71%
    Market cap $175.71MP/E —
    $5.05$9.13
  • BOOM
    DMC Global Inc. Common Stock
    $5.33
    ▲ 1.72%
    Market cap $154.47MP/E —
    $4.69$9.2
  • ZJYL
    JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares
    $2.08
    ▼ 3.48%
    Market cap $150.59MP/E 110.49
    $1.53$8.48
  • LAKE
    Lakeland Industries Inc. Common Stock
    $9.09
    ▼ 3.09%
    Market cap $117.15MP/E —
    $7.15$17.72
  • HDSN
    Hudson Technologies Inc. Common Stock
    $5.01
    ▼ 0.60%
    Market cap $237.90MP/E 23.59
    $4.64$9.65
  • YDDL
    One and One Green Technologies. Inc Class A Ordinary Shares
    $1.18
    ▲ 0.00%
    Market cap $98.62MP/E 4.78
    $1.25$16.23
  • AGPU
    Axe Compute Inc. Common Stock
    $7.68
    ▼ 8.68%
    Market cap $96.32MP/E —
    $1.03$13.98

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
219.2K
Disposed
160.4K

Institutional Ownership

March 31, 2026

Total shares held
17.83M
Total value held
$98.92M
Institutional holders
120
Top holders this quarter
  • Unknown1.65M
  • Unknown1.20M
  • Unknown1.08M
  • Unknown1.04M
  • Unknown859.5K
  • Unknown845.2K
  • Unknown642.4K
  • Unknown613.5K
  • Unknown586.2K
  • Unknown580.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.